Hormonal analyses have become indispensable for managing high-risk pregnancies. They allow an early diagnosis of chronic disturbances in the nutritive function of the placenta and of fetal growth retardation. However, except for a few clinics [2, 9] hormonal assays are frequently used only when the placental dysfunction is already clinically manifest (premature labor, discrepancy between uterine size and estimated gestational age, etc.) or if there are serious risk factors from the history. Not infrequently "placental insufficiency" is not accompanied by any clinical Symptoms [10, 18] and thus escapes diagnosis, or at least early diagnosis. Early diagnosis, however, is the decisive prerequisite for successful therapy which must have its goal a mature healthy newbom with a normal birth weight. Biochemical parameters in contrast to clinical and biophysical obstetric indicators are currently the only ones which give any direct Information about the function of the placenta. Measurements of placental perfusion with radioisotopes cannot be used in clinical routine äs yet. Therefore, hormonal assays should indicate disturbances in placental function earlier than the other variables. Thus, the medically correct procedure would consist of *Presented in part at the 41 st meeting of the German Society for Gynecology and Obstetrics, Hamburg, September 28 to October 2,1976. hormonal assays for all pregnant women äs a preventive measure, thus facilitating either exclusion or early diagnosis of a placental risk. A suitable endocrine surveillance program for pregnant patients prior to the 30 th week leading to a marked decrease of the number of small-fordates infants has not been described to date. We have recently published an endocrine model [18] in which we postulate that generally there is a primary impairment of placental function and that fetal manifestations are secondary (except for primary fetal anomalies). An endocrine surveillance program for the early recognition of placental functional disturbances should therefore primarily utilize placental indicators. The estrogen excretion in the urine äs well äs the estriol concentration in the plasma is an early fetal but not an early placental indicator [9, 18] . Therefore, we Interpret pathological excretions of estrogen äs representing already present fetal damage and consequently we attempt to avoid this advanced stage of disturbed fetoplacental function. A suitable early placental indicator in our experience is the urinary excretion of pregnanediol [18] and somewhat less the concentration of human placental lactogen (HPL) in the serum [WOLFRUM, to be published]. The present study attempts to give further proof of the usefulness of the described model. Thus the determination of total estrogen was included in the program. In addition, the study was to answer threequestions: l.What is the earliest time at which "placental insufficiency" can be diagnosed by means of pregnanediol excretion? 2. Is it possible to predict the future function of the placenta and the further growth of the fetus from hormonal fmdings between the 20 th and 30th week of gestation? 3. Is it possible to decrease significantly the number of premature and dysmature births by early diagnosis and appropriately timed preventive measures?
l Material and Methods
Analytical methods described earlier [19, 20] and controls [18] were used. The preventive program admitted at no cost pregnant women who were at least in the 19th and not beyond the 23 rd week of gestation. Delivery in our hospital was not a condition for acceptance into the program. The contact with patients was maintained through an informational brochure via the practicing obstetricians. Each patient had a determination of the biparietal skull diameter by udtrasound in Order to verify the estimated date of confinement. If the calculated gestational age from the last menstrual period and the ultrasonographic findings deviated from each other by more than two weeks, the patient was measured again with ultrasound four weeks later. At the first clinic visit each patient was extensively informed about the purpose of the program and the technique of urine collections. After the ultrasonography , three comb ine d estrogen and pregnanediol determinations were carried out at intervals of two weeks. Thus, the program extended from the 20th to the 27th week of gestation. Pregnanediol excretion was considered pathological if at least two of the three values were below the potentially pathologic ränge (Fig. 1 avoidance of stress, and proscription of smoking but there were occasional hormonal and ultrasound controls. We define "placental risk" äs follows:
l.History: one or more perinatal deaths (except for unequivocally non-placental causes of death) or one or more children with a birth weight of equal to or under 2700 grams or two or more abortions or severe toxemia. 2.Current pregnancy: placental weight less than 500 g* or macroscopically markedly infarcted placenta orpathological findings in the placental histology** or hypertension in early pregnancy*** or threatened abortion or elderly primipara (over 32 years) or elderly multipara (over 40 years) or young primipara (under 20 years). The presence of even one risk factor from history or current pregnancy was considered äs indicative of "placental risk." Only one factor was applied to each patient. If several factors were present, the clinically more severe was used: current pregnancy over past pregnancies, dead fetus over hypotrophic fetus, hypotrophic fetus over toxemia, placental weight or abnormal histology over hypertension, etc. [3, 12, 14] have shown that the limit in this social, economic, geographic and ethnical environment is higher [9] . In order to account for this fact and to make comparisons possible [9] we drew the limit at 2700 grams. This corresponds to the 15th percentile of Lubchenco. Locally applicable percentiles are not yet known. Newborns from the beginning of the 38th week were considered äs mature [9] . Otherwise newborns with a weight of equal to or under 2700 grams were classified äs described by KLINGMÜLLER-AHTING et al. [9] äs hypotrophic mature, eutrophic premature, and hypotrophic premature. Correspondingly, the 15th percentile of Lubchenco was used. Twins were excluded from these statistics.
Results

Correlation between birth weight and hormonal assays
The birthweights of the infants with normal assays and of those with pathological results of hormonal assays were tested with the chi square test äs to normal distribution. It was found that for the group with pathological hormonal assay, 2 = 5.443. The significance threshold for p = 0.05 for 5 degrees of freedom is 2 = 11,070. For the group with normal hormonal assay it was found that 2 = 5,004. The level of significance for p = 0.05 for 8 degrees of freedom is 2 = 15.507. Thus the distribution of frequency for the birthweights in both groups can be considered äs normal and consequently the t-test may be used for a test of significant differences. The average birth weight of all children with normal hormonal findings was 3468 grams, for those with pathological results it was 3210 grams. The difference in the t-test is highly significant (p < 0.001). This expresses the fact that in the group with pathological hormonal findings children with relatively low birth weights After the very highly significant correlation between pregnanediol excretion and nutritive placental function had been found, we tested with the four field χ 2 test whether the group with pathological hormonal findings contained significantly more "placental risk" (70 times = 58.8% of our cases with pathological hormonal findings) than the group with normal hormonal Status (138 times = 36.2% of all cases with normal hormonal findings). The test is highly significant (p < 0.001).
In combination with the positive correlation between birth weight and hormonal findings, it is thus shown thatthe named "placental risk factors" are indeed placental risk factors with a potential impairment of the nutritive function. These results are summarized in Tab. I. According to our model most of the later hypotrophic newborns (10 of 15) | are still in risk group II (only pathological pregnanediol findings) at this stage of pregnancy.
In 48 cases there was no "placental risk", yet the hormonal findings were thought to be pathological (40.3% of all pathological hormonal findings). Of these pregnancies 45 ended with the birth of a mature,normal-weightinfant,one with prematurity, and two with dysmaturity.
Cases with "placental risk" in the history and currently normal findings were analysed separately. There were 41 such pregnancies. It was seen that with normal hormonal findings in 39 cases (95.1 %) a mature, normal-weight child was born (one eutrophic premature with 2500 grams/47 cm and a hypotrophic mature with 2650 grams/48 cm).
Cases with normal hormonal Status resulting in a low weight infant were analysed separately. There were 17 such pregnancies (3.4%). In 14 cases (2.8%) the children were eutrophic prematures and in 3 cases (0.6%) hypotrophic mature infants (2460 g, 2650 g, 2700 g). The number of falsely normal hormonal assays resulting in hypotrophic newborns thus is less than l%of all births (16.6% of all hypotrophic newborns). The distribution of hypotrophic newborns and eutrophic prematures in risk group I and II-IV is shown in Tab. I. [17] showed that about 9.7% of the infants born in Hamburg in 1975 weighed equal to or less than 2700 grams. Of these about 4.2% were eutrophic prematures and about 5.5 %werehypotrophicmature and premature infants. Thus, our surveillance group and the average in Hamburg did not differ significantly in respect to premature infants (p > 0.1). In respect to prematures, our total group in 1975 was slightly (p <0.1 %) above the Hamburg average. The number of dystrophic births in our surveillance group (3.6%) is slightly (p < 0.1) less than the Hamburg average but in the total group (2.6%) the difference is markedly significant (p < 0.001). 3 Discussion
Comparison of premature and dystrophic infants
From our recentiy described endocrine model [18] it may be expected that a pathological hormonal Status between the 20th and 27th week shoiüd primarily consistof abnormal pregnanediol findings. In 105 women (88.2%) of a total of 119 with pathological hormonal Status the pregnanediol excretion only was pathological. Thus,our expectations were confirmed and our model was further corroborated. There is a highly significant correlation between the presence of "placental risk" (Tab. ) and the hormonal Status (Tab. I) äs well äs between mean birth weight and hormonal Status (Tab. I). Thus, it has been further proven that pregnanediol excretion äs determined by our method [20] However, this includes a relatively high proportion of "false pathological" hormonal findings. It is difficult to assess how high this proportion actually is. In addition to methodological limitations and uncertainties (losses during the analytical procedure) which cannot be abolished entirely, a "false pathological" hormonal Status can also be explained on morphological reasons. It is known that the placenta has considerably capabüities for compensation i.e. morphologically in particular the ability of the new formation of endocrine active syncytiotrophoblast from LANGHANS' cells [5, 6, 7] . Possibly this finds an endocrine expression in (insufficient syncytiotrophoblast) later becomes normal or tends towards normalization äs has been observed by us [18] . Even a failure of pregnanediol excretion to normalize does not necessarily indicate a clinically manifest fetal growth retardation. In cases of pathological pregnanediol excretion during the entire second half of pregnancy with simultaneously normal weight infants we usually observe a normal estrogen rise until deliveiy. Evidently,in these cases the residual capacity of the placenta is sufficient for normal fetal supply. Thus, it is possible that our patient groups contain a higher number of these mild, possibly transient forms of placental insufficiency because in comparison to a hypothetical group of randomily selected patients more thantwice the number of cases with "placental risk" are included in the survey. This indicates a certain selection of the patients by the referring obstetricians who collaborated with us even though a selection was not initially planned. A clinically unremarkable course of pregnancy or the normal weight of a newbom do not prove that the placental function has been entirely normal throughout. It is obviously important for obstetric management that the number of "false normal" findings is low. This condition is met by our program. It would be desirable to carry out endocrine surveillance in all pregnancies between the 20th and 30th week at a time when the placental indicators are of particular significance. After the 30th week, estrogen excretion äs an indicator of fetal growth assumes greater importance without any doubt. The total number of prematures in our hospital was not significantly decreased by the endocrine surveillance, even though the surveillance group did contain significantly less prematures than the total patient population in 1974 and 1975 (Tab. III). We had determined earlier [18] that there is not always a correlation between premature onset of labor and the excretion of hormones. It is remarkable, however, that the prematures with normal hormonal Status were most typically eutrophic premature (Tab. I). Evidently, in these cases, the premature onset of labor is not brought on by a utero-placental insufficiency, but possibly more by aneuroexcitatory hypersensibility [4] . The primary indication for hormonal analysis is the diagnosis of chronic impairment of nutritive placental function. Therefore, one should expect from an endocrine surveillance program, a decrease in the number of dystrophic births. We were able to prove that (Tab. III, column 5d, lines, 1,2, 3). Our results to the best of our knowledge also represent the only tabulation in which there is a marked decrease of hypotrophic newborns between 1973 and 1975.
We consider two factors äs responsible: early diagnosis by determination of pregnanediol excretion after the 20 th week and tesiuting timely long-term preventive measures. There is a wide-spreadopinion that hormonal assays in 24 hour urines are not practicable in ambulatory practice because of the uncertainty of proper collecting techniques. We do not find this to be true. The number of hormonal assays which could not be analysed properly because of faulty urine collections in our study (äs identified by creatinine determinations) is negligibly low. In our experience only two conditions need to be met in order to demonstrate practicability in this respect: l. there must be no languäge barriers; 2. the patient must be motivated. There should be littie argument that pregnant women are pärticularly easily motivated.
Summary
The prognostic value of hormonal assays in pregnant women during the second trimester in regard to the risk for premature and dysmature births was studied. Based on a recently published endocrine model, since early 1974 we performed three combined total estrogen and pregnanediol assays in the 24 hour urine in 500 "unselected" women between the 20th and 27 th week of gestation. We believe this to be the first description of a systematical endocrine surveillance program in this early stage of gestation. The current study uses afundamentauy different approach than has been used thus far in perinatal medicine, where hormonal assays are carried out only after the 30th week of gestation. These then left often only the decision whether the pregnancy should be terminated prematurely. Thus, intrauterine fetal death but not intrauterine growth retardation and frequently associated irreversible brain damage of the infant might be avoided. This procedure represents a dead-end street in so far äs it may aid in lowering perinatal mortality but not perinatal morbidity. The early starting point of our surveillance (20 th week) was chosen because we think that premature termination of pregnancy is not necessarily the only consequence when dealing with "placental insufficiency." If this emergency solution is to be avoided, two prerequisites must be met: 1. early diagnosis of placental functional disturbance and 2. timely long-term preventive measures. Hormonal diagnosis, in our opinion, is currently the only chance for early recognition of disturbed nutritive placental function acceptable to large scale use. All other indicators (ultrasound, fundus height, etc.) show pathological results only after the disturbed growth of the fetus is already manifest and time for treatment has passed. Gestational age was measured by means of ultrasonographic determination of the biparietal skull diameter in the 20 th week. Hormonal assays were divided into two groups, normal and pathological. With normal hormonal assays the patient was further monitored endocrinologically only if there were concurrentclinicäl placental risk factors. With pathological hormonal findings the assays were repeated during a following control period of several weeks. Women with increased pathological findings (10% of the total group) were further cared for in an intensive program and will be reported on separately. Hormonal findings were statistically correlated to the birth weight of the children and a defined "placental risk" from history or current pregnancy. We then compared internally our premature and dysmature births from 1973 to 1975. For thispurpose the children equal to or under 2700 grams were classified äs hypotrophic mature, eutrophic premature and hypotrophic premature. This study had the following results:
1. The endocrine model described by us was again confirmed. From the pathological hormonal findings 8 8.2% were due to pathological pregnanediol excretion (N ^ 105), only 3.3% (N = 4) due to pathological estrogen excretion, the remainder (N = 10) had both pathological estrogen and pregnanediol excretion. Thus, the endocrine surveillance was 119 times pathological (23.8% of all pregnancies, Tab. I). According to our model fetuses who later become hypotrophic in this early stage of pregnancy usually are in risk group II (10 of 15). There were too few cases to allow percentage calculations^of the hypotrophic newborns in correlation with the corresponding risk groups. However, äs early äs the 20th to 27 th week, the same risk tendencies are recognizable äs have been recently described for a group of 222 pregnant patients in later stages of pregnancy: the risk of intrauterine growth retardation increases markedly from risk group I (0.7% hypotrophic infants) via II (10 of 105 newborns hypotrophic) and III (one newborn off our hypotrophic) to risk group IV (four newborns of 10 hypotrophic). 2. There is a highly significant correlation between pregnanediol excretion by our method and the mean birth weight of the newborns (Tab. I). This is further proof that pregnanediol excretion by our method is an early indicator of diminished nutritive placental function. By measuring pregnanediol excretion "placental insufficiency" can be diagnosed äs early äs between the 20 th and27th week. 3. A "placental risk" is defined from the patient's past history of placental risk factors and those during the current pregnancy (Tab. II). This "placental risk" is found significantly more often associated with a pathological hormonal assay than with normal hormonal assay (Tab. I). This association together with the positive correlation between pregnanediol excretion and mean birth weight prove that these factors of "placental risk" indeed are risk factors related to the placenta such äs potentially early diminished nutritive function.
With "placental risk" in the past history and currently normal hormonal assay, 39 of 41 (95.1%) infants were born mature and with a normal weight (there was one premature and one dystrophic newborn). In the absence of a "placental risk" but with pathological hormonal findings there were normal infants in 45 of 48 cases (93.7%) (one premature and two dystrophic births). 4. In only 3 (16.6%) of 18 cases of hypotrophic newborns the hormonal results in the second trimester were normal. In contrast the hormonal findings in 14 of 17 cases (82.3%) of eutrophic prematures was normal. 5. Points 2, 3, and 4 above allow the conclusion that in case of normal hormonal findings between the 20 th and 27 th week a placental risk and thus the risk of intrauterine growth retardation may be ruled out with a high degree of certainty. With pathological hormonal findings in the surveillance period it is necessary to repeat the tests during the following weeks (control period) and to select between the 30 th and 33rd week those cases in which impairment of the fetus must be assumed. The latter require an intensive program until delivery. 6. The system described allows an early diagnosis of disturbed nutritive placental function and thus timely preventive measures. These include in addition to the treatment of clinical Symptoms, general rest and decreased stress to the woman even before the 30 th week, possibly longer periods of bed-rest if necessary. Mots-cles: Fonction placentaire nutritive, oestrogenes complets, pregnandiol, Programme prophylactique endocrinologique, retardement de la croissance intra-uterine.
